Stephen Basil Thomas - 01 Jan 2025 Form 4 Insider Report for Climb Bio, Inc. (CLYM)

Role: Director
Signature: Emily Pimblett, as Attorney-in-Fact
Issuer symbol: CLYM
Transactions as of: 01 Jan 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Jan 2025, 16:15:05 UTC
Previous filing: 27 Jun 2024
Next filing: 27 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLYM	Common Stock	Options Exercise		+50,188	+48%		154,095	01 Jan 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLYM	Restricted Stock Units	Options Exercise	$0	-50,188	-50%	$0.000000	50,187	01 Jan 2025	Common Stock	50,188		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
F2	Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3	The RSUs were granted on June 27, 2024 and will vest as to 50% of the shares on January 1, 2025, as to 25% of the shares on March 27, 2025 and as to the remaining 25% of the shares on June 27, 2025, subject to the Reporting Person's continued service.